Anxiety: all studies (page 216) - The Consciousness Library

A Social Media-Based Mindfulness Psycho-Behavioral Intervention (MCARE) for Patients With Acute Coronary Syndrome: Randomized Controlled Trial.

Journal of Medical Internet Research February 20, 2024 Huijing Zou, Sek Ying Chair, Bilong Feng et al. 15 citations

Psychological distress is common among patients with acute coronary syndrome (ACS) and has considerable adverse impacts on disease progression and health outcomes. Mindfulness-based intervention is a promising complementary approach to address patients' psychological needs and promote holistic well-being. This study aims to examine the effects of a social media-based mindfulness...

DOI: 10.2196/48557 Full text Anxiety Depression Acute coronary syndrome Cardiac rehabilitation +5

Effect of mindfulness-based interventions on people with prehypertension or hypertension: a systematic review and meta-analysis of randomized controlled trials.

BMC cardiovascular disorders February 14, 2024 Qiongshan Chen, Hui Liu, Shizheng Du 23 citations

Hypertension and prehypertension have been widely recognized as the main contributors of global mortality. Evidence shows mindfulness-based interventions may reduce blood pressure and improve mental health. However, the effect of mindfulness-based interventions on blood pressure and mental health has not been fully understood. Potential studies published before May 24th 2023 were identified by...

DOI: 10.1186/s12872-024-03746-w Full text Anxiety Depression Mindfulness Blood pressure +1

Antidepressant- and anxiolytic-like activities and acute toxicity evaluation of the Psilocybe cubensis mushroom in experimental models in mice.

Journal of Ethnopharmacology February 10, 2024 Alberto Hernández-león, Raúl Iván Escamilla-Orozco, Aylín R. Tabal-Robles et al. 29 citations

Central nervous system (CNS) diseases can be diverse and usually present with comorbidity, as in the case of depression and anxiety. Despite alternatives like Psilocybe mushrooms for mental health there is no basic research to evidence their CNS benefits. To evaluate the anxiolytic- and antidepressant-like effects, as well as the acute toxicity of P. cubensis mushroom. First, the acute toxicity...

DOI: 10.1016/j.jep.2023.117415 Full text Depression Psilocybin Mental health anxiety Mood disorders +7

Emotion regulation effects of Ayahuasca in experienced subjects during implicit aversive stimulation: An fMRI study.

Journal of Ethnopharmacology February 10, 2024 Tiago Arruda Sanchez, Lucas Rego Ramos, Felipe Araujo et al. 12 citations

Ayahuasca is a beverage used in Amazonian traditional medicine and it has been part of the human experience for millennia as well as other different psychoactive plants. Although Ayahuasca has been proposed as potentially therapeutic as an anxiolytic and antidepressant, whilst no studies have been carried out so far investigating their direct effect on brain emotional processing. This study...

DOI: 10.1016/j.jep.2023.117430 Full text DMT Ayahuasca Anxiety Dimethyltryptamine +8

Methylone is a rapid-acting neuroplastogen with less off-target activity than MDMA

Frontiers in Neuroscience February 7, 2024 Jennifer Warner-Schmidt, Martin Stogniew, Blake Mandell et al. 6 citations

BackgroundPost-traumatic stress disorder (PTSD) is a highly prevalent psychiatric disorder that can become chronic and debilitating when left untreated. Available pharmacotherapies are limited, take weeks to show modest benefit and remain ineffective for up to 40% of patients. Methylone is currently in clinical development for the treatment of PTSD. Preclinical studies show rapid, robust and...

DOI: 10.3389/fnins.2024.1353131 Full text PTSD Depression Anxiety Empathogen +2

Practicing self-hypnosis to reduce chronic pain: A qualitative exploratory study of HYlaDO.

British Journal of Pain February 2024 Rémi Caron-Trahan, Anne-Eva Jusseaux, Maryse Aubin et al.

Background: Nearly a quarter of Canada's population suffers from chronic pain, a long-lasting medical condition marked by physical pain and psychological suffering. Opioids are the primary treatment for pain management in this condition; yet, this approach involves several undesirable side effects. In contrast to this established approach, non-pharmacological interventions, such as medical...

DOI: 10.1177/20494637231200324 Full text Anxiety Hypnosis Chronic pain Group intervention +1

Mindfulness, coping, and optimism as mechanisms of change in the 3RP-NF intervention.

Journal of Clinical Psychology February 1, 2024 Victoria A Grunberg, Jafar Bakhshaie, Heena R Manglani et al. 4 citations

Neurofibromatosis (NF) is chronic neurogenetic condition that increases risk for poor quality of life, depression, and anxiety. Given the lack of biomedical treatments, we developed the "Relaxation Response Resiliency for NF" (3RP-NF) program to improve psychosocial outcomes among adults with NF. To move toward effectiveness testing, we must understand mechanisms that explained treatment...

DOI: 10.1002/jclp.23623 Full text Anxiety Depression Mechanisms of change Neurofibromatosis +1

Preliminary evidence of psychological improvements and increased maternal-fetal attachment associated with a mindfulness sleep programme: secondary analysis of uncontrolled data in 11 pregnant women with insomnia disorder.

Journal of Sleep Research February 1, 2024 David A Kalmbach, Anthony N Reffi, Jason C Ong et al. 9 citations

Treating insomnia during pregnancy improves sleep and depressed mood. However, given well-established links between poor sleep and a broad spectrum of adverse maternal outcomes, the benefits of insomnia care may reach beyond sleep and depression. The present study evaluated the preliminary efficacy of 'Perinatal Understanding of Mindful Awareness for Sleep' (PUMAS)-a mindfulness sleep programme...

DOI: 10.1111/jsr.14040 Full text Anxiety Meditation Pumas Attachment +5

Pharmacotherapy of Psychological Disorders Using Psychedelic Drugs: A Treatise for Psychiatrists

Current Psychiatry Research and Reviews January 21, 2024 Payal Ghosh, Debjeet Sur 1 citation

: Psychedelics are currently being examined once more as potential remedies for untreatable biological illnesses after decades of research problems. They are frequently regarded to be physically safe and do not frequently lead to dependency or addiction. The use of psychedelic substances in the treatment of mental illness and the adoption of the Substance Act of 1970 has classified psychedelic...

DOI: 10.2174/0126660822258502231120074036 Psilocybin Anxiety Addiction MDMA +6

Psilocybe cubensis extract potently prevents fear memory recall and freezing behavior in short- but not long-term in a rat model of posttraumatic stress disorder.

Behavioral Neuroscience January 18, 2024 Zahra Ghofrani-Jahromi, Sarah Nouri-Darehno, Mehrsa Rahimi-Danesh et al. 22 citations

Psilocybe cubensis is a species of psilocybin mushroom (magic mushroom) of moderate potency whose principal active compounds are psilocybin and psilocin. Recent studies have shown the significant procognitive and mood-enhancer effects of Psilocybe cubensis. However, evidence is so limited, especially in preclinical studies. We aimed to investigate the effect of Psilocybe cubensis extract on...

DOI: 10.1037/bne0000579 Psilocybin Anxiety